Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer

NCT02350712 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Patritumab
DRUG: Cetuximab
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

Daiichi Sankyo